Dialysis provider DaVita Inc. (NYSE:DVA) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 6% year on year to $3.42 billi...
Dialysis provider DaVita Inc. (NYSE:DVA) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 6% year on year to $3.42 billi...
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what you need to know. DaVita beat analysts’ reven...
DaVita has had an impressive run over the past six months as its shares have beaten the S&P 500 by 12.5%. The stock now trades at $150.12, marking a 15.9% ga...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa...
As of March 17, 2026, the American healthcare landscape is undergoing its most significant structural transformation in decades. The traditional hospital-centric model is rapidly giving way to a decentralized, outpatient-first ecosystem, fueled by an aging demographic often referred to as the "Silver Tsunami." This shift is not merely a matter
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
